14Jan 2024
Efficacy of three benznidazole dosing strategies for adults living with chronic Chagas disease (MULTIBENZ)

Efficacy of three benznidazole dosing strategies for adults living with chronic Chagas disease (MULTIBENZ)

The MULTIBENZ trial compares the parasitological efficacy and safety of three benznidazole regimens in adult patients with chronic Chagas disease. The results showed sustained parasitological negativity in 54%, 61%, and 58% of the control, low-dose, and short-treatment groups, respectively, with no significant differences. Adverse events were observed in 76% of participants, but discontinuations were less frequent in the short treatment group. The study suggests that a shorter treatment duration might offer similar efficacy, improved adherence, and increased treatment coverage, warranting confirmation in a phase 3 trial.

  • #general medicine

Like

Save

Share